Banbury meeting: Integrating Exposomics into the Biomedical Enterprise
The purpose of this Banbury Center meeting is to develop an operational definition for exposomics that aligns with broader goals to seek fundamental knowledge and apply it.
Discussions focused on:
- Developing an operational definition* of exposomics for biomedical research;
- Identifying the components of the biomedical enterprise that will benefit most from exposomics (research, discovery, clinical trials, diagnosis, etc);
- Outlining conceptual and technical innovations that will be needed to establish exposomics a bona fide -omics discipline
Two main outputs were expected:
- A two-page white paper that provides the rationale and utility of the operational definition
- An academic manuscript that explains how the operational definition can be used to advance the field of exposomics
Our work will provide stakeholders and the scientific community with an unambiguous definition of the exposome that can be used to advance our understanding of the environmental contributors to human disease and health.
At the meeting, there were about twenty participants, most of them US based. The participants from Europe, Jana Klánová, Robert Barouki and Roel Vermeulen representing both the EIRENE RI and the IHEN project.
More articles
-
EIRENE begins the next phase of preparations for becoming a European Research Infrastructure Consortium following the first meeting of the Board of Governmental Representatives. The meeting marked a significant milestone in the development of EIRENE, which has completed its preparatory phase and is now moving towards implementation.
-
EIRENE IMP project officially launched in Prague
The EIRENE IMP project was officially launched during a two-day hybrid kick-off meeting held on 25–26 June 2026 at the Technology Centre Prague. The opening event brought together project partners, representatives of national nodes of the EIRENE RI research infrastructure, and project managers from the beneficiary and the European Commission.